Bookmark and Share Print This Page
Delaware Bio Board

Delaware BioScience Association Directors

John N. Austin, Ph.D.
Associate Vice President for Research & Sponsored Programs
Delaware State University

Izak Bahar
Vice President, R&D Assay Development
Siemens Healthcare Diagnostics

Joan I. Barber, Ph.D.
Professor, Biology and Chemistry
Delaware Technical Community College

Tamera Brown
Associate Director, State Government Affairs & Policy
Merck & Co., Inc.

J. Michael Bowman
State Director & Associate Director
DE Small Business & Technology Development Center & OEIP

Patricia A. Cannon, MSM
Business Development Manager
Delaware Economic Development Office

Frank Casty, MD, FACP
Clinical Development Head Critical Care
Novartis Pharmaceuticals Corporation

Richard Dashefsky
Senior Counsel
Christiana Care Health System

Fran DiNuzzo
ILC Dover LP

Dale Ervin
Director of Operations
Fraunhofer USA CMB

T. Ben Hsu, Ph.D.
Chief Administrative Officer
QPS Holdings, LLC

Daminder Johar
Manager, Business Development
DuPont Industrial Biosciences

Kelvin Lee, Ph.D.
Delaware Biotechnology Institute

William Mongan
Executive Director, US Business Development
AstraZeneca Pharmaceuticals LP

Pamela Murphy
Vice President Investor Relations & Corporate Communications
Incyte Corporation

Helen Stimson
Vice President & General Manager Chemistries & Supplies Division
Agilent Technologies, Inc.

Greg Tronto
Gore PharmBio Product
Business Development Leader, Drug Delivery

W. L. Gore & Associates, Inc.

Ian Wright, CBiol. MSB
CEO of the Advanced Clinical Biosystems Institute
Cedars-Sinai Medical Center

Ray Yin, Ph.D.
ANP Technologies, Inc.

Christopher Yochim
Director External Relations, SPBD (ret.)
AstraZeneca Pharmaceuticals LP



Delaware BioScience Association Officers

Christopher Yochim, Chairman

Jennifer Kmiec, Immediate Past Chairperson

Bob Dayton, President

J. Michael Bowman, Treasurer

John H. Taylor III, Secretary